MAGEA2B Antikörper (C-Term)
-
- Target Alle MAGEA2B Antikörper anzeigen
- MAGEA2B (Melanoma Antigen Family A, 2B (MAGEA2B))
- Bindungsspezifität
- C-Term
- Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser MAGEA2B Antikörper ist unkonjugiert
- Applikation
- ELISA, Western Blotting (WB)
- Spezifität
- MAGEA2 Antibody detects endogenous levels of total MAGEA2.
- Aufreinigung
- The antiserum was purified by peptide affinity chromatography using SulfoLinkTM Coupling Resin (Thermo Fisher Scientific).
- Immunogen
- A synthesized peptide derived from human MAGEA2, corresponding to a region within C-terminal amino acids.
- Isotyp
- IgG
-
-
- Applikationshinweise
- WB 1:1000-3000, ELISA(peptide) 1:20000-1:40000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 mg/mL
- Buffer
- Rabbit IgG in phosphate buffered saline , pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20 °C. Stable for 12 months from date of receipt.
- Haltbarkeit
- 12 months
-
- Target
- MAGEA2B (Melanoma Antigen Family A, 2B (MAGEA2B))
- Andere Bezeichnung
- MAGEA2, MAGEA2B (MAGEA2B Produkte)
- Synonyme
- MAGE2 antikoerper, MAGEA2 antikoerper, MAGE family member A2B antikoerper, MAGEA2B antikoerper
- Hintergrund
-
Description: Reduces p53/TP53 transactivation function through recruitment of HDAC3 to p53/TP53 transcription sites. Also represses p73/TP73 activity. Proposed to enhance ubiquitin ligase activity of RING-type zinc finger-containing E3 ubiquitin-protein ligases. In vitro enhances ubiquitin ligase activity of TRIM28 and stimulates p53/TP53 ubiquitination by TRIM28 potentially in presence of Ubl-conjugating enzyme UBE2H. Proposed to act through recruitment and/or stabilization of the Ubl-conjugating enzyme (E2) at the E3:substrate complex. May play a role in embryonal development and tumor transformation or aspects of tumor progression. In vitro promotes cell viability in melanoma cell lines. Antigen recognized on a melanoma by autologous cytolytic T-lymphocytes. Negatively regulates acetylation and sumoylation of PML and represses PML-induced p53/TP53 acetylation and activation.
Gene: MAGEA2, MAGEA2B
- Molekulargewicht
- 35 kDa
- Gen-ID
- 266740, 4101
- UniProt
- P43356
-